Nice talk from @piet_ost outlining approaches in recurrent/met #HSPC to optimise local control
Clear evidence for metastasis directed therapy (MDT) ... less clear locally ... case for leaving prostate bed alone, esp given most tissue toxicity occurs there
#BMUC2024@bmuc_be
Excited to unveil the biological landscape of penile cancer at @ASCO#GU24. Stop by poster board E7 for a journey into the penile cancer single-cell RNA sequencing wonderland 🧬🔬
Big shoutout to @MaartenAlbersen for all the guidance 🙏🏼
#BMUC23 is a wrap. - 260 attendees: urologists, medical oncologists, researchers, industry all brought together.
- 29 (inter)national faculty
- Very practical information applicable to routine oncology care.
🔹SEE YOU IN 2024🔹
Great to have attended the #BMUC23 conference! 🔬📊
The perspective 👀 from each specialty was truly insightful
Kudos 👏 to the team for putting together an excellent event!
#BMUC23#urology#conference
Radiotherapy for Penile cancer is now supported by the @Uroweb guidelines! @VedangMurthy as the expert on stage! Amazing knowledge dissemination! Dose and field are important in adjuvant CRT. #BMUC23
#GU23 very practical data to help inform patients on probability of testosterone recovery, time to recovery, based on ADT duration and baseline levels #pcsm@OncoAlert
@SbrtSean@piet_ost yes, PSMA PET before sRT is included in the Primordium study. Please support this trial testing if 6mo Apa improves ppMFS https://t.co/JHq5KkpK1b
🔥🔥 primary endpoint analysis from @nickva1 of PACE-A; SBRT versus robotic prostatectomy for #prostatecancer RCT. Co-primary toxicity endpoints (continence/bowel) #GU23@ASCO@OncoAlert@NHSuk. N=123, SBRT had ⬇️ pad use ⬇️ sexual dysfunction but ⬆️ bowel bother. All low grade.
Joe O’Sullivan presents CHHiP trial update 10-year data confirms 60/20 hypofractionated #radiotherapy as the standard of care for #prostatecancer (mostly intermediate). Good to see late significant GI/GU toxicity <1-2% at 10 years! @asco#GU23#radonc#pcsm@OncoAlert
Looking forward to hosting our (inter)national speakers for the BMUC23 conference on multiD management in uro-oncology with @PaulSargos@VedangMurthy and more! Register here: https://t.co/EJniitnONX